Beta-blockers induce class II MHC antigens on psoriatic keratinocytes.
Czernielewski
J
J
Schalla
W
W
Desbas
C
C
Brun
P
P
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000368:Aged; D004817:Epidermis / Q000276:immunology*; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II / Q000032:analysis*; D006801:Humans; D007633:Keratins / Q000276:immunology*; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced*
D000319:Adrenergic beta-Antagonists; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D007633:Keratins